Investor:
Renana Ashkenazi
Leadership team:
Avi Veidman, Lotan Chorev, Eliron Amir
Website:
www.nucleai.ai

Nucleai leads the Spatial Biology revolution in precision medicine by improving the cancer diagnostics process and treatment.

  • SDG: 3 – Good health and wellbeing
  • Spatial Biology
  • Precision Medicine
  • AI
  • Machine Learning
  • Healthcare

The Grove Ventures team is with us from the get-go. They are focused on creating value at every step of the way.

Avi Veidman, CEO and Co-Founder, Nucleai

Top news

AI-Assisted Cancer Diagnosis Company Nucleai Raises $5M

AI cancer treatment startup Nucleai raises $6.5 million in series A round

Nucleai raises $33 million for spatial biology drug development platform

Nucleai Adds $14 Million in a Financing Led by Merck’s VC Arm